š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The objectives of this study are to evaluate the therapeutic equivalence of...
Status
Completed
Location
Douglas Young, MD
Start Date
2017-10-26
Trial ID
NCT03332303
Treatments Being Tested
To compare pharmacodynamic vasoconstriction response profile of Clocortolon...
Status
Completed
Location
WayCro
Start Date
2018-03-02
Trial ID
NCT04358770
Treatments Being Tested
To compare the safety and efficacy profiles of Tazarotene Cream, 0.1 % to t...
Status
Completed
Location
Altman Dermatology Associates
Start Date
2014-05
Trial ID
NCT02160678
Treatments Being Tested
This is a randomized, multi-center, double-blind, placebo-controlled, multi...
Status
Completed
Location
Ce3
Start Date
2013-06
Trial ID
NCT01874626
Treatments Being Tested
To establish the bioequivalence between test drug, Pimecrolimus Cream, 1% w...
Status
Completed
Location
Research Facility 6
Start Date
2016-02-29
Trial ID
NCT03107611
Treatments Being Tested
The purpose of this study is to compare the safety and efficacy profiles of...
Status
Completed
Location
Altman Dermatology Associates
Start Date
2014-05
Trial ID
NCT02160665
Treatments Being Tested
This project will be a three-group controlled 6-wk feeding study where all ...
Status
Completed
Location
The Ohio State University
Start Date
2018-07-05
Trial ID
NCT06449287
randomized, double-blind, placebo controlled...
Status
Completed
Location
WAYcro
Start Date
2018-02-23
Trial ID
NCT05148689
Treatments Being Tested
This phase III study was conducted to establish the clinical bioequivalence...
Status
Completed
Location
Universal Biopharma Research Institute Inc.
Start Date
2018-04-10
Trial ID
NCT03973775
Treatments Being Tested
To compare safety and efficacy of Perrigo's drug product compared to an FDA...
Status
Completed
Location
Comprehensive Clinical Trials, LLC
Start Date
2016-05
Trial ID
NCT02770365
Treatments Being Tested